| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | androsterone dehydrogenase (B-specific) activity | 3.69e-10 | 4 | 89 | 4 | GO:0047042 | |
| GeneOntologyMolecularFunction | ketoreductase activity | 3.69e-10 | 4 | 89 | 4 | GO:0045703 | |
| GeneOntologyMolecularFunction | chlordecone reductase activity | 3.69e-10 | 4 | 89 | 4 | GO:0047743 | |
| GeneOntologyMolecularFunction | trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity | 1.84e-09 | 5 | 89 | 4 | GO:0047115 | |
| GeneOntologyMolecularFunction | 15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity | 1.84e-09 | 5 | 89 | 4 | GO:0047020 | |
| GeneOntologyMolecularFunction | 17-beta-ketosteroid reductase (NADPH) activity | 1.84e-09 | 5 | 89 | 4 | GO:0072555 | |
| GeneOntologyMolecularFunction | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity | 1.84e-09 | 5 | 89 | 4 | GO:0047006 | |
| GeneOntologyMolecularFunction | lithocholic acid binding | 1.84e-09 | 5 | 89 | 4 | GO:1902121 | |
| GeneOntologyMolecularFunction | ketosteroid monooxygenase activity | 1.84e-09 | 5 | 89 | 4 | GO:0047086 | |
| GeneOntologyMolecularFunction | Delta4-3-oxosteroid 5beta-reductase activity | 1.84e-09 | 5 | 89 | 4 | GO:0047787 | |
| GeneOntologyMolecularFunction | geranylgeranyl reductase activity | 5.49e-09 | 6 | 89 | 4 | GO:0045550 | |
| GeneOntologyMolecularFunction | 17-beta-hydroxysteroid dehydrogenase (NADP+) activity | 1.28e-08 | 7 | 89 | 4 | GO:0072582 | |
| GeneOntologyMolecularFunction | 5alpha-androstane-3beta,17beta-diol dehydrogenase activity | 2.55e-08 | 8 | 89 | 4 | GO:0047024 | |
| GeneOntologyMolecularFunction | androsterone dehydrogenase activity | 2.55e-08 | 8 | 89 | 4 | GO:0047023 | |
| GeneOntologyMolecularFunction | enone reductase activity | 2.55e-08 | 8 | 89 | 4 | GO:0035671 | |
| GeneOntologyMolecularFunction | androstan-3-alpha,17-beta-diol dehydrogenase activity | 4.57e-08 | 9 | 89 | 4 | GO:0047044 | |
| GeneOntologyMolecularFunction | NADP+ binding | 4.57e-08 | 9 | 89 | 4 | GO:0070401 | |
| GeneOntologyMolecularFunction | testosterone 17-beta-dehydrogenase (NADP+) activity | 7.59e-08 | 10 | 89 | 4 | GO:0047045 | |
| GeneOntologyMolecularFunction | bile acid binding | 7.59e-08 | 10 | 89 | 4 | GO:0032052 | |
| GeneOntologyMolecularFunction | aldose reductase (NADPH) activity | 3.57e-07 | 14 | 89 | 4 | GO:0004032 | |
| GeneOntologyMolecularFunction | retinal dehydrogenase activity | 3.57e-07 | 14 | 89 | 4 | GO:0001758 | |
| GeneOntologyMolecularFunction | estradiol 17-beta-dehydrogenase [NAD(P)+] activity | 1.69e-06 | 20 | 89 | 4 | GO:0004303 | |
| GeneOntologyMolecularFunction | all-trans-retinol dehydrogenase (NAD+) activity | 3.66e-06 | 24 | 89 | 4 | GO:0004745 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors | 5.01e-06 | 56 | 89 | 5 | GO:0016903 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase (NAD+) activity | 5.11e-06 | 26 | 89 | 4 | GO:0004022 | |
| GeneOntologyMolecularFunction | NADPH binding | 5.11e-06 | 26 | 89 | 4 | GO:0070402 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase (NADP+) activity | 5.98e-06 | 27 | 89 | 4 | GO:0008106 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase [NAD(P)+] activity | 9.25e-06 | 30 | 89 | 4 | GO:0018455 | |
| GeneOntologyMolecularFunction | aldo-keto reductase (NADPH) activity | 1.21e-05 | 32 | 89 | 4 | GO:0004033 | |
| GeneOntologyMolecularFunction | steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 1.37e-05 | 33 | 89 | 4 | GO:0033764 | |
| GeneOntologyMolecularFunction | testosterone dehydrogenase [NAD(P)+] activity | 1.38e-05 | 11 | 89 | 3 | GO:0030283 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor | 1.54e-05 | 34 | 89 | 4 | GO:0016628 | |
| GeneOntologyMolecularFunction | steroid dehydrogenase activity | 2.69e-05 | 39 | 89 | 4 | GO:0016229 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen | 2.98e-05 | 40 | 89 | 4 | GO:0016709 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor | 6.18e-05 | 48 | 89 | 4 | GO:0016620 | |
| GeneOntologyMolecularFunction | indanol dehydrogenase activity | 1.17e-04 | 4 | 89 | 2 | GO:0047718 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor | 1.49e-04 | 60 | 89 | 4 | GO:0016655 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-CH group of donors | 1.69e-04 | 62 | 89 | 4 | GO:0016627 | |
| GeneOntologyMolecularFunction | NADP binding | 1.69e-04 | 62 | 89 | 4 | GO:0050661 | |
| GeneOntologyMolecularFunction | lipoteichoic acid binding | 4.07e-04 | 7 | 89 | 2 | GO:0070891 | |
| GeneOntologyMolecularFunction | testosterone dehydrogenase (NAD+) activity | 6.93e-04 | 9 | 89 | 2 | GO:0047035 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on NAD(P)H | 8.62e-04 | 95 | 89 | 4 | GO:0016651 | |
| GeneOntologyMolecularFunction | monocarboxylic acid binding | 1.34e-03 | 107 | 89 | 4 | GO:0033293 | |
| GeneOntologyMolecularFunction | monooxygenase activity | 1.75e-03 | 115 | 89 | 4 | GO:0004497 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | 1.76e-03 | 194 | 89 | 5 | GO:0016705 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 2.51e-03 | 127 | 89 | 4 | GO:0016616 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 2.87e-03 | 18 | 89 | 2 | GO:0008569 | |
| GeneOntologyMolecularFunction | steroid binding | 2.97e-03 | 133 | 89 | 4 | GO:0005496 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH-OH group of donors | 3.39e-03 | 138 | 89 | 4 | GO:0016614 | |
| GeneOntologyMolecularFunction | proteasome binding | 3.54e-03 | 20 | 89 | 2 | GO:0070628 | |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | 3.75e-03 | 231 | 89 | 5 | GO:0005085 | |
| GeneOntologyMolecularFunction | lipid binding | CD6 SVIL TLR2 MTTP AKR1C3 APPL1 AKR1C4 BAIAP3 AKR1C1 AKR1C2 ITPR2 | 4.40e-03 | 988 | 89 | 11 | GO:0008289 |
| GeneOntologyBiologicalProcess | response to jasmonic acid | 2.95e-10 | 4 | 87 | 4 | GO:0009753 | |
| GeneOntologyBiologicalProcess | progesterone catabolic process | 2.95e-10 | 4 | 87 | 4 | GO:0006709 | |
| GeneOntologyBiologicalProcess | cellular response to jasmonic acid stimulus | 2.95e-10 | 4 | 87 | 4 | GO:0071395 | |
| GeneOntologyBiologicalProcess | C21-steroid hormone catabolic process | 2.95e-10 | 4 | 87 | 4 | GO:0008208 | |
| GeneOntologyBiologicalProcess | farnesol metabolic process | 1.47e-09 | 5 | 87 | 4 | GO:0016487 | |
| GeneOntologyBiologicalProcess | farnesol catabolic process | 1.47e-09 | 5 | 87 | 4 | GO:0016488 | |
| GeneOntologyBiologicalProcess | negative regulation of isoprenoid metabolic process | 1.47e-09 | 5 | 87 | 4 | GO:0045827 | |
| GeneOntologyBiologicalProcess | sesquiterpenoid catabolic process | 1.47e-09 | 5 | 87 | 4 | GO:0016107 | |
| GeneOntologyBiologicalProcess | olefinic compound catabolic process | 1.47e-09 | 5 | 87 | 4 | GO:0120256 | |
| GeneOntologyBiologicalProcess | negative regulation of retinoic acid biosynthetic process | 1.47e-09 | 5 | 87 | 4 | GO:1900053 | |
| GeneOntologyBiologicalProcess | sesquiterpenoid metabolic process | 4.40e-09 | 6 | 87 | 4 | GO:0006714 | |
| GeneOntologyBiologicalProcess | polyprenol catabolic process | 4.40e-09 | 6 | 87 | 4 | GO:0016095 | |
| GeneOntologyBiologicalProcess | response to prostaglandin D | 1.02e-08 | 7 | 87 | 4 | GO:0071798 | |
| GeneOntologyBiologicalProcess | cellular response to prostaglandin D stimulus | 1.02e-08 | 7 | 87 | 4 | GO:0071799 | |
| GeneOntologyBiologicalProcess | regulation of retinoic acid biosynthetic process | 1.02e-08 | 7 | 87 | 4 | GO:1900052 | |
| GeneOntologyBiologicalProcess | regulation of retinoic acid receptor signaling pathway | 2.29e-08 | 21 | 87 | 5 | GO:0048385 | |
| GeneOntologyBiologicalProcess | daunorubicin metabolic process | 3.66e-08 | 9 | 87 | 4 | GO:0044597 | |
| GeneOntologyBiologicalProcess | doxorubicin metabolic process | 6.08e-08 | 10 | 87 | 4 | GO:0044598 | |
| GeneOntologyBiologicalProcess | regulation of isoprenoid metabolic process | 6.08e-08 | 10 | 87 | 4 | GO:0019747 | |
| GeneOntologyBiologicalProcess | negative regulation of vitamin metabolic process | 6.08e-08 | 10 | 87 | 4 | GO:0046137 | |
| GeneOntologyBiologicalProcess | polyketide metabolic process | 6.08e-08 | 10 | 87 | 4 | GO:0030638 | |
| GeneOntologyBiologicalProcess | aminoglycoside antibiotic metabolic process | 6.08e-08 | 10 | 87 | 4 | GO:0030647 | |
| GeneOntologyBiologicalProcess | regulation of testosterone biosynthetic process | 9.53e-08 | 11 | 87 | 4 | GO:2000224 | |
| GeneOntologyBiologicalProcess | terpenoid catabolic process | 9.53e-08 | 11 | 87 | 4 | GO:0016115 | |
| GeneOntologyBiologicalProcess | retinoic acid biosynthetic process | 2.86e-07 | 14 | 87 | 4 | GO:0002138 | |
| GeneOntologyBiologicalProcess | isoprenoid catabolic process | 2.86e-07 | 14 | 87 | 4 | GO:0008300 | |
| GeneOntologyBiologicalProcess | diterpenoid biosynthetic process | 3.89e-07 | 15 | 87 | 4 | GO:0016102 | |
| GeneOntologyBiologicalProcess | testosterone biosynthetic process | 5.17e-07 | 16 | 87 | 4 | GO:0061370 | |
| GeneOntologyBiologicalProcess | negative regulation of hormone metabolic process | 5.17e-07 | 16 | 87 | 4 | GO:0032351 | |
| GeneOntologyBiologicalProcess | retinoic acid receptor signaling pathway | 5.35e-07 | 38 | 87 | 5 | GO:0048384 | |
| GeneOntologyBiologicalProcess | regulation of vitamin metabolic process | 8.64e-07 | 18 | 87 | 4 | GO:0030656 | |
| GeneOntologyBiologicalProcess | hormone catabolic process | 1.67e-06 | 21 | 87 | 4 | GO:0042447 | |
| GeneOntologyBiologicalProcess | terpenoid biosynthetic process | 1.67e-06 | 21 | 87 | 4 | GO:0016114 | |
| GeneOntologyBiologicalProcess | retinal metabolic process | 1.67e-06 | 21 | 87 | 4 | GO:0042574 | |
| GeneOntologyBiologicalProcess | ketone catabolic process | 1.67e-06 | 21 | 87 | 4 | GO:0042182 | |
| GeneOntologyBiologicalProcess | parturition | 2.04e-06 | 22 | 87 | 4 | GO:0007567 | |
| GeneOntologyBiologicalProcess | glycoside metabolic process | 2.04e-06 | 22 | 87 | 4 | GO:0016137 | |
| GeneOntologyBiologicalProcess | progesterone metabolic process | 2.04e-06 | 22 | 87 | 4 | GO:0042448 | |
| GeneOntologyBiologicalProcess | tertiary alcohol metabolic process | 2.04e-06 | 22 | 87 | 4 | GO:1902644 | |
| GeneOntologyBiologicalProcess | cellular response to prostaglandin stimulus | 2.46e-06 | 23 | 87 | 4 | GO:0071379 | |
| GeneOntologyBiologicalProcess | primary alcohol catabolic process | 2.46e-06 | 23 | 87 | 4 | GO:0034310 | |
| GeneOntologyBiologicalProcess | regulation of ketone biosynthetic process | 4.11e-06 | 26 | 87 | 4 | GO:0010566 | |
| GeneOntologyBiologicalProcess | positive regulation of epithelial cell apoptotic process | 5.41e-06 | 60 | 87 | 5 | GO:1904037 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA splicing, via spliceosome | 5.60e-06 | 28 | 87 | 4 | GO:0048025 | |
| GeneOntologyBiologicalProcess | polyprenol metabolic process | 6.47e-06 | 29 | 87 | 4 | GO:0016093 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA processing | 6.47e-06 | 29 | 87 | 4 | GO:0050686 | |
| GeneOntologyBiologicalProcess | secondary metabolic process | 9.34e-06 | 67 | 87 | 5 | GO:0019748 | |
| GeneOntologyBiologicalProcess | positive regulation of endothelial cell apoptotic process | 9.70e-06 | 32 | 87 | 4 | GO:2000353 | |
| GeneOntologyBiologicalProcess | response to fatty acid | 1.08e-05 | 69 | 87 | 5 | GO:0070542 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA splicing | 1.10e-05 | 33 | 87 | 4 | GO:0033119 | |
| GeneOntologyBiologicalProcess | steroid catabolic process | 1.24e-05 | 34 | 87 | 4 | GO:0006706 | |
| GeneOntologyBiologicalProcess | olefinic compound biosynthetic process | 1.40e-05 | 35 | 87 | 4 | GO:0120255 | |
| GeneOntologyBiologicalProcess | response to prostaglandin | 1.57e-05 | 36 | 87 | 4 | GO:0034694 | |
| GeneOntologyBiologicalProcess | isoprenoid biosynthetic process | 1.57e-05 | 36 | 87 | 4 | GO:0008299 | |
| GeneOntologyBiologicalProcess | retinoic acid metabolic process | 2.40e-05 | 40 | 87 | 4 | GO:0042573 | |
| GeneOntologyBiologicalProcess | cellular response to fatty acid | 2.92e-05 | 42 | 87 | 4 | GO:0071398 | |
| GeneOntologyBiologicalProcess | cellular response to calcium ion | 3.54e-05 | 88 | 87 | 5 | GO:0071277 | |
| GeneOntologyBiologicalProcess | positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | 3.71e-05 | 217 | 87 | 7 | GO:0051897 | |
| GeneOntologyBiologicalProcess | C21-steroid hormone metabolic process | 3.86e-05 | 45 | 87 | 4 | GO:0008207 | |
| GeneOntologyBiologicalProcess | protein localization to kinetochore | 3.90e-05 | 16 | 87 | 3 | GO:0034501 | |
| GeneOntologyBiologicalProcess | protein localization to condensed chromosome | 3.90e-05 | 16 | 87 | 3 | GO:1903083 | |
| GeneOntologyBiologicalProcess | alcohol catabolic process | 4.59e-05 | 47 | 87 | 4 | GO:0046164 | |
| GeneOntologyBiologicalProcess | response to calcium ion | 6.17e-05 | 161 | 87 | 6 | GO:0051592 | |
| GeneOntologyBiologicalProcess | prostaglandin metabolic process | 9.17e-05 | 56 | 87 | 4 | GO:0006693 | |
| GeneOntologyBiologicalProcess | prostanoid metabolic process | 9.83e-05 | 57 | 87 | 4 | GO:0006692 | |
| GeneOntologyBiologicalProcess | ketone biosynthetic process | 9.83e-05 | 57 | 87 | 4 | GO:0042181 | |
| GeneOntologyBiologicalProcess | regulation of hormone metabolic process | 1.05e-04 | 58 | 87 | 4 | GO:0032350 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA metabolic process | 1.27e-04 | 115 | 87 | 5 | GO:1903312 | |
| GeneOntologyBiologicalProcess | regulation of attachment of spindle microtubules to kinetochore | 1.38e-04 | 24 | 87 | 3 | GO:0051988 | |
| GeneOntologyBiologicalProcess | sperm motility | 1.67e-04 | 193 | 87 | 6 | GO:0097722 | |
| GeneOntologyBiologicalProcess | phosphatidylinositol 3-kinase/protein kinase B signal transduction | 2.10e-04 | 382 | 87 | 8 | GO:0043491 | |
| GeneOntologyBiologicalProcess | cellular response to alcohol | 2.25e-04 | 130 | 87 | 5 | GO:0097306 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound catabolic process | 2.57e-04 | 73 | 87 | 4 | GO:1901616 | |
| GeneOntologyBiologicalProcess | regulation of endothelial cell apoptotic process | 2.71e-04 | 74 | 87 | 4 | GO:2000351 | |
| GeneOntologyBiologicalProcess | xenobiotic metabolic process | 3.28e-04 | 141 | 87 | 5 | GO:0006805 | |
| GeneOntologyBiologicalProcess | icosanoid metabolic process | 3.38e-04 | 142 | 87 | 5 | GO:0006690 | |
| GeneOntologyBiologicalProcess | endothelial cell apoptotic process | 3.49e-04 | 79 | 87 | 4 | GO:0072577 | |
| GeneOntologyBiologicalProcess | cellular response to xenobiotic stimulus | 3.55e-04 | 222 | 87 | 6 | GO:0071466 | |
| GeneOntologyBiologicalProcess | cellular response to corticosteroid stimulus | 3.84e-04 | 81 | 87 | 4 | GO:0071384 | |
| GeneOntologyBiologicalProcess | regulation of epithelial cell apoptotic process | 4.62e-04 | 152 | 87 | 5 | GO:1904035 | |
| GeneOntologyBiologicalProcess | regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | 5.29e-04 | 334 | 87 | 7 | GO:0051896 | |
| GeneOntologyBiologicalProcess | positive regulation of reactive oxygen species metabolic process | 5.49e-04 | 89 | 87 | 4 | GO:2000379 | |
| GeneOntologyBiologicalProcess | retinoid metabolic process | 5.49e-04 | 89 | 87 | 4 | GO:0001523 | |
| GeneOntologyBiologicalProcess | hormone-mediated signaling pathway | 5.85e-04 | 244 | 87 | 6 | GO:0009755 | |
| GeneOntologyBiologicalProcess | negative regulation of lipid biosynthetic process | 5.97e-04 | 91 | 87 | 4 | GO:0051055 | |
| GeneOntologyBiologicalProcess | diterpenoid metabolic process | 6.74e-04 | 94 | 87 | 4 | GO:0016101 | |
| GeneOntologyBiologicalProcess | aldehyde metabolic process | 7.02e-04 | 95 | 87 | 4 | GO:0006081 | |
| GeneOntologyBiologicalProcess | glycosyl compound metabolic process | 7.30e-04 | 96 | 87 | 4 | GO:1901657 | |
| GeneOntologyBiologicalProcess | protein localization to chromosome, centromeric region | 7.39e-04 | 42 | 87 | 3 | GO:0071459 | |
| GeneOntologyBiologicalProcess | cilium movement | 8.31e-04 | 261 | 87 | 6 | GO:0003341 | |
| GeneOntologyBiologicalProcess | response to estrogen | 9.50e-04 | 103 | 87 | 4 | GO:0043627 | |
| GeneOntologyBiologicalProcess | terpenoid metabolic process | 1.02e-03 | 105 | 87 | 4 | GO:0006721 | |
| GeneOntologyBiologicalProcess | primary alcohol metabolic process | 1.06e-03 | 106 | 87 | 4 | GO:0034308 | |
| GeneOntologyBiologicalProcess | regulation of steroid biosynthetic process | 1.06e-03 | 106 | 87 | 4 | GO:0050810 | |
| GeneOntologyBiologicalProcess | flagellated sperm motility | 1.15e-03 | 186 | 87 | 5 | GO:0030317 | |
| GeneOntologyBiologicalProcess | lipid catabolic process | 1.16e-03 | 382 | 87 | 7 | GO:0016042 | |
| GeneOntologyBiologicalProcess | regulation of ketone metabolic process | 1.23e-03 | 189 | 87 | 5 | GO:0010565 | |
| GeneOntologyBiologicalProcess | heart development | 1.31e-03 | 757 | 87 | 10 | GO:0007507 | |
| GeneOntologyBiologicalProcess | epithelial cell apoptotic process | 1.32e-03 | 192 | 87 | 5 | GO:1904019 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated signaling pathway | 1.65e-03 | 202 | 87 | 5 | GO:0141193 | |
| GeneOntologyCellularComponent | RZZ complex | 5.48e-05 | 3 | 90 | 2 | GO:1990423 | |
| GeneOntologyCellularComponent | 9+0 motile cilium | 2.72e-04 | 6 | 90 | 2 | GO:0097728 | |
| MousePheno | parturition failure | 1.12e-07 | 10 | 69 | 4 | MP:0012010 | |
| MousePheno | hypermyelination | 1.75e-07 | 11 | 69 | 4 | MP:0010050 | |
| MousePheno | increased oligodendrocyte number | 3.76e-07 | 13 | 69 | 4 | MP:0010160 | |
| MousePheno | increased circulating progesterone level | 7.12e-07 | 15 | 69 | 4 | MP:0005186 | |
| MousePheno | long stride length | 7.12e-07 | 15 | 69 | 4 | MP:0010540 | |
| MousePheno | long gestation period | 7.12e-07 | 15 | 69 | 4 | MP:0002293 | |
| MousePheno | abnormal gestational length | 1.58e-06 | 18 | 69 | 4 | MP:0002292 | |
| MousePheno | dysmyelination | 2.48e-06 | 20 | 69 | 4 | MP:0013438 | |
| MousePheno | abnormal respiratory system physiology | ILF3 TMTC3 AP1B1 KCNJ3 TLR2 AKR1C3 PDS5A AKR1C4 PRKDC DNAH5 AKR1C1 AKR1C2 AK7 MUSK DNAH11 HELLS | 5.52e-06 | 897 | 69 | 16 | MP:0002133 |
| MousePheno | decreased oligodendrocyte number | 6.36e-06 | 25 | 69 | 4 | MP:0009808 | |
| MousePheno | abnormal respiratory motile cilium physiology | 1.18e-05 | 29 | 69 | 4 | MP:0011055 | |
| MousePheno | prolonged diestrus | 1.35e-05 | 30 | 69 | 4 | MP:0009011 | |
| MousePheno | abnormal parturition | 2.00e-05 | 33 | 69 | 4 | MP:0002907 | |
| MousePheno | biventricular, ambiguous atrioventricular connection | 2.40e-05 | 2 | 69 | 2 | MP:0011511 | |
| MousePheno | abnormal diestrus | 2.54e-05 | 35 | 69 | 4 | MP:0009010 | |
| MousePheno | enhanced coordination | 3.54e-05 | 38 | 69 | 4 | MP:0003858 | |
| MousePheno | prolonged estrous cycle | 3.92e-05 | 39 | 69 | 4 | MP:0009006 | |
| MousePheno | abnormal stride length | 5.14e-05 | 82 | 69 | 5 | MP:0012690 | |
| MousePheno | abnormal anxiety-related response | NDST3 DCDC2 KCNJ3 MC2R SPPL3 AKR1C3 AKR1C4 TMEM35A ECPAS BAIAP3 AKR1C1 AKR1C2 BTBD3 | 5.69e-05 | 740 | 69 | 13 | MP:0001362 |
| MousePheno | biventricular, discordant atrioventricular connection | 7.18e-05 | 3 | 69 | 2 | MP:0011510 | |
| MousePheno | immotile respiratory cilia | 7.45e-05 | 17 | 69 | 3 | MP:0011649 | |
| MousePheno | decreased vocalization | 7.59e-05 | 46 | 69 | 4 | MP:0020351 | |
| MousePheno | respiratory system inflammation | 1.02e-04 | 220 | 69 | 7 | MP:0002405 | |
| MousePheno | abnormal circulating progesterone level | 1.05e-04 | 50 | 69 | 4 | MP:0005184 | |
| MousePheno | abnormal motile cilium physiology | 1.14e-04 | 51 | 69 | 4 | MP:0013209 | |
| MousePheno | abnormal respiratory epithelium physiology | 1.14e-04 | 51 | 69 | 4 | MP:0014200 | |
| MousePheno | abnormal oligodendrocyte morphology | 1.14e-04 | 51 | 69 | 4 | MP:0000953 | |
| MousePheno | abnormal cilium physiology | 1.33e-04 | 53 | 69 | 4 | MP:0013208 | |
| MousePheno | increased stereotypic behavior | 1.33e-04 | 53 | 69 | 4 | MP:0001409 | |
| MousePheno | abnormal progesterone level | 1.43e-04 | 54 | 69 | 4 | MP:0011384 | |
| MousePheno | situs inversus totalis | 1.90e-04 | 23 | 69 | 3 | MP:0011252 | |
| MousePheno | heart left ventricle hypertrophy | 2.93e-04 | 65 | 69 | 4 | MP:0002625 | |
| MousePheno | left pulmonary isomerism | 4.69e-04 | 31 | 69 | 3 | MP:0003178 | |
| MousePheno | abnormal fear/anxiety-related behavior | NDST3 DCDC2 KCNJ3 MC2R SPPL3 AKR1C3 AKR1C4 TMEM35A ECPAS BAIAP3 AKR1C1 AKR1C2 BTBD3 | 4.86e-04 | 919 | 69 | 13 | MP:0002065 |
| MousePheno | superior-inferior ventricles | 4.96e-04 | 7 | 69 | 2 | MP:0011254 | |
| MousePheno | situs inversus with levocardia | 4.96e-04 | 7 | 69 | 2 | MP:0011253 | |
| MousePheno | increased circulating hormone level | SLC16A2 TLR2 MC2R AKR1C3 APPL1 AKR1C4 TMEM35A AKR1C1 AKR1C2 VAV2 | 5.09e-04 | 578 | 69 | 10 | MP:0014456 |
| MousePheno | left-sided isomerism | 6.17e-04 | 34 | 69 | 3 | MP:0000542 | |
| MousePheno | left atrial isomerism | 6.60e-04 | 8 | 69 | 2 | MP:0008461 | |
| MousePheno | decreased circulating LDL cholesterol level | 7.79e-04 | 84 | 69 | 4 | MP:0000183 | |
| MousePheno | atrioventricular septal defect | 7.79e-04 | 84 | 69 | 4 | MP:0010412 | |
| MousePheno | abdominal situs inversus | 8.45e-04 | 9 | 69 | 2 | MP:0011249 | |
| MousePheno | decreased B cell proliferation | 8.51e-04 | 86 | 69 | 4 | MP:0005093 | |
| MousePheno | abnormal atrioventricular septum morphology | 8.89e-04 | 87 | 69 | 4 | MP:0010592 | |
| MousePheno | oxidative stress | 9.14e-04 | 152 | 69 | 5 | MP:0003674 | |
| MousePheno | abnormal gait | 9.89e-04 | 520 | 69 | 9 | MP:0001406 | |
| MousePheno | increased hormone level | SLC16A2 TLR2 MC2R AKR1C3 APPL1 AKR1C4 TMEM35A AKR1C1 AKR1C2 VAV2 | 1.13e-03 | 641 | 69 | 10 | MP:0014454 |
| MousePheno | heart right ventricle hypertrophy | 1.15e-03 | 42 | 69 | 3 | MP:0000276 | |
| MousePheno | abnormal circulating LDL cholesterol level | 1.25e-03 | 163 | 69 | 5 | MP:0000181 | |
| Domain | ALDOKETO_REDUCTASE_1 | 9.03e-08 | 10 | 87 | 4 | PS00798 | |
| Domain | Aldo/ket_reductase_CS | 9.03e-08 | 10 | 87 | 4 | IPR018170 | |
| Domain | Aldo/keto_reductase | 9.03e-08 | 10 | 87 | 4 | IPR020471 | |
| Domain | ALDOKETO_REDUCTASE_2 | 9.03e-08 | 10 | 87 | 4 | PS00062 | |
| Domain | ALDOKETO_REDUCTASE_3 | 9.03e-08 | 10 | 87 | 4 | PS00063 | |
| Domain | ARM-type_fold | ELMO3 AP1B1 AP2B1 MTOR CIP2A PDS5A PRKDC API5 ECPAS ITPR2 XPO7 | 4.90e-07 | 339 | 87 | 11 | IPR016024 |
| Domain | ARM-like | 5.07e-07 | 270 | 87 | 10 | IPR011989 | |
| Domain | - | 7.66e-07 | 16 | 87 | 4 | 3.20.20.100 | |
| Domain | NADP_OxRdtase_dom | 9.98e-07 | 17 | 87 | 4 | IPR023210 | |
| Domain | Aldo_ket_red | 9.98e-07 | 17 | 87 | 4 | PF00248 | |
| Domain | Aldo/ket_red/Kv-b | 9.98e-07 | 17 | 87 | 4 | IPR001395 | |
| Domain | - | 9.16e-06 | 222 | 87 | 8 | 1.25.10.10 | |
| Domain | DH_1 | 1.11e-05 | 63 | 87 | 5 | PS00741 | |
| Domain | Spectrin/alpha-actinin | 1.43e-05 | 32 | 87 | 4 | IPR018159 | |
| Domain | SPEC | 1.43e-05 | 32 | 87 | 4 | SM00150 | |
| Domain | RhoGEF | 1.62e-05 | 68 | 87 | 5 | SM00325 | |
| Domain | RhoGEF | 1.86e-05 | 70 | 87 | 5 | PF00621 | |
| Domain | DH_2 | 1.86e-05 | 70 | 87 | 5 | PS50010 | |
| Domain | DH-domain | 2.00e-05 | 71 | 87 | 5 | IPR000219 | |
| Domain | - | 2.00e-05 | 71 | 87 | 5 | 1.20.900.10 | |
| Domain | - | 2.14e-05 | 2 | 87 | 2 | 2.60.40.1150 | |
| Domain | Clathrin_b-adaptin_app_Ig-like | 2.14e-05 | 2 | 87 | 2 | IPR013037 | |
| Domain | GDS_CDC24_CS | 3.19e-05 | 39 | 87 | 4 | IPR001331 | |
| Domain | AP_complex_bsu_1_2_4 | 6.42e-05 | 3 | 87 | 2 | IPR016342 | |
| Domain | B2-adapt-app_C | 6.42e-05 | 3 | 87 | 2 | PF09066 | |
| Domain | B-adaptin_app_sub_C | 1.28e-04 | 4 | 87 | 2 | IPR015151 | |
| Domain | B2-adapt-app_C | 1.28e-04 | 4 | 87 | 2 | SM01020 | |
| Domain | AP_beta | 2.13e-04 | 5 | 87 | 2 | IPR026739 | |
| Domain | FATC | 2.13e-04 | 5 | 87 | 2 | PF02260 | |
| Domain | CRAL-TRIO_dom | 2.94e-04 | 28 | 87 | 3 | IPR001251 | |
| Domain | PH | 3.18e-04 | 278 | 87 | 7 | SM00233 | |
| Domain | FAT | 3.18e-04 | 6 | 87 | 2 | PS51189 | |
| Domain | FATC | 3.18e-04 | 6 | 87 | 2 | PS51190 | |
| Domain | FAT | 3.18e-04 | 6 | 87 | 2 | PF02259 | |
| Domain | PIK-rel_kinase_FAT | 3.18e-04 | 6 | 87 | 2 | IPR003151 | |
| Domain | FATC_dom | 3.18e-04 | 6 | 87 | 2 | IPR003152 | |
| Domain | PIK_FAT | 3.18e-04 | 6 | 87 | 2 | IPR014009 | |
| Domain | Beta2_adaptin/TBP_C_dom | 3.18e-04 | 6 | 87 | 2 | IPR012295 | |
| Domain | FATC | 3.18e-04 | 6 | 87 | 2 | SM01343 | |
| Domain | - | 3.18e-04 | 6 | 87 | 2 | 3.30.310.10 | |
| Domain | HEAT_REPEAT | 3.19e-04 | 70 | 87 | 4 | PS50077 | |
| Domain | PH_DOMAIN | 3.25e-04 | 279 | 87 | 7 | PS50003 | |
| Domain | Spectrin_repeat | 3.27e-04 | 29 | 87 | 3 | IPR002017 | |
| Domain | PH_domain | 3.32e-04 | 280 | 87 | 7 | IPR001849 | |
| Domain | Coatomer/calthrin_app_sub_C | 5.90e-04 | 8 | 87 | 2 | IPR009028 | |
| Domain | DHC_N1 | 5.90e-04 | 8 | 87 | 2 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 5.90e-04 | 8 | 87 | 2 | IPR013594 | |
| Domain | Clathrin_a/b/g-adaptin_app_Ig | 7.56e-04 | 9 | 87 | 2 | IPR008152 | |
| Domain | Alpha_adaptinC2 | 7.56e-04 | 9 | 87 | 2 | PF02883 | |
| Domain | Alpha_adaptinC2 | 7.56e-04 | 9 | 87 | 2 | SM00809 | |
| Domain | Coatomer/clathrin_app_Ig-like | 1.37e-03 | 12 | 87 | 2 | IPR013041 | |
| Domain | Dynein_heavy_chain_D4_dom | 1.88e-03 | 14 | 87 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 1.88e-03 | 14 | 87 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 1.88e-03 | 14 | 87 | 2 | IPR013602 | |
| Domain | DHC_N2 | 1.88e-03 | 14 | 87 | 2 | PF08393 | |
| Domain | MT | 1.88e-03 | 14 | 87 | 2 | PF12777 | |
| Domain | AAA_8 | 1.88e-03 | 14 | 87 | 2 | PF12780 | |
| Domain | ATPase_dyneun-rel_AAA | 1.88e-03 | 14 | 87 | 2 | IPR011704 | |
| Domain | AAA_5 | 1.88e-03 | 14 | 87 | 2 | PF07728 | |
| Domain | DHC_fam | 2.17e-03 | 15 | 87 | 2 | IPR026983 | |
| Domain | Clathrin/coatomer_adapt-like_N | 2.17e-03 | 15 | 87 | 2 | IPR002553 | |
| Domain | Adaptin_N | 2.17e-03 | 15 | 87 | 2 | PF01602 | |
| Domain | Dynein_heavy_dom | 2.17e-03 | 15 | 87 | 2 | IPR004273 | |
| Domain | Dynein_heavy | 2.17e-03 | 15 | 87 | 2 | PF03028 | |
| Domain | PI3/4_kinase_CS | 2.17e-03 | 15 | 87 | 2 | IPR018936 | |
| Domain | - | 2.32e-03 | 391 | 87 | 7 | 2.30.29.30 | |
| Domain | - | 2.47e-03 | 16 | 87 | 2 | 1.10.1070.11 | |
| Domain | PI3Kc | 2.47e-03 | 16 | 87 | 2 | SM00146 | |
| Domain | HEAT | 2.50e-03 | 58 | 87 | 3 | IPR000357 | |
| Domain | PI3/4_kinase_cat_dom | 3.13e-03 | 18 | 87 | 2 | IPR000403 | |
| Domain | PI3_PI4_kinase | 3.13e-03 | 18 | 87 | 2 | PF00454 | |
| Domain | PI3_4_KINASE_3 | 3.13e-03 | 18 | 87 | 2 | PS50290 | |
| Domain | PI3_4_KINASE_1 | 3.13e-03 | 18 | 87 | 2 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 3.13e-03 | 18 | 87 | 2 | PS00916 | |
| Domain | PH_dom-like | 3.73e-03 | 426 | 87 | 7 | IPR011993 | |
| Domain | SRCR | 4.25e-03 | 21 | 87 | 2 | PF00530 | |
| Domain | PH | 4.34e-03 | 229 | 87 | 5 | PF00169 | |
| Pathway | WP_BENZOAPYRENE_METABOLISM | 8.18e-08 | 9 | 73 | 4 | M39344 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_METALS_TO_KEAP1_NRF2_SIGNALIG_PATHWAY | 8.18e-08 | 9 | 73 | 4 | M47817 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_BENZO_A_PYRENRE_TO_CYP_MEDIATED_METABOLISM | 2.12e-07 | 11 | 73 | 4 | M47812 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_24_HYDROXYCHOLESTEROL | 4.57e-07 | 13 | 73 | 4 | M17842 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_24_HYDROXYCHOLESTEROL | 4.57e-07 | 13 | 73 | 4 | MM14747 | |
| Pathway | WP_GLUCOCORTICOID_BIOSYNTHESIS | 6.37e-07 | 14 | 73 | 4 | M46449 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_27_HYDROXYCHOLESTEROL | 6.37e-07 | 14 | 73 | 4 | M27074 | |
| Pathway | WP_MINERALOCORTICOID_BIOSYNTHESIS | 6.37e-07 | 14 | 73 | 4 | M46453 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_27_HYDROXYCHOLESTEROL | 6.37e-07 | 14 | 73 | 4 | MM14748 | |
| Pathway | REACTOME_SYNTHESIS_OF_PROSTAGLANDINS_PG_AND_THROMBOXANES_TX | 8.65e-07 | 15 | 73 | 4 | MM14870 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL | 5.44e-06 | 23 | 73 | 4 | M1926 | |
| Pathway | REACTOME_PREDNISONE_ADME | 5.44e-06 | 23 | 73 | 4 | MM16639 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL | 5.44e-06 | 23 | 73 | 4 | MM14741 | |
| Pathway | REACTOME_RA_BIOSYNTHESIS_PATHWAY | 1.23e-05 | 28 | 73 | 4 | MM15188 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS | 2.42e-05 | 33 | 73 | 4 | M5967 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS | 2.42e-05 | 33 | 73 | 4 | MM14737 | |
| Pathway | REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM | 7.68e-05 | 44 | 73 | 4 | M499 | |
| Pathway | REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS | 8.40e-05 | 45 | 73 | 4 | MM15344 | |
| Pathway | REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM | 8.40e-05 | 45 | 73 | 4 | MM14751 | |
| Pathway | REACTOME_SIGNALING_BY_RETINOIC_ACID | 1.18e-04 | 49 | 73 | 4 | MM15186 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TCR_PLCG_ITPR_SIGNALING_PATHWAY | 1.22e-04 | 19 | 73 | 3 | M47733 | |
| Pathway | KEGG_STEROID_HORMONE_BIOSYNTHESIS | 1.85e-04 | 55 | 73 | 4 | M14933 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_YERSINIA_YOPH_TO_TCR_NFAT_SIGNALING_PATHWAY | 2.62e-04 | 5 | 73 | 2 | M48994 | |
| Pathway | REACTOME_ARACHIDONIC_ACID_METABOLISM | 2.76e-04 | 61 | 73 | 4 | MM14861 | |
| Pathway | REACTOME_DRUG_ADME | 3.74e-04 | 119 | 73 | 5 | MM15692 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 4.69e-04 | 70 | 73 | 4 | M16794 | |
| Pathway | PID_RAC1_REG_PATHWAY | 9.87e-04 | 38 | 73 | 3 | M241 | |
| Pubmed | Structure and activity of the murine type 5 17beta-hydroxysteroid dehydrogenase gene(1). | 4.19e-11 | 4 | 90 | 4 | 10500239 | |
| Pubmed | 4.19e-11 | 4 | 90 | 4 | 19487289 | ||
| Pubmed | Cloning and chromosomal localization of mouse 20alpha-hydroxysteroid dehydrogenase gene. | 4.19e-11 | 4 | 90 | 4 | 14967952 | |
| Pubmed | 4.19e-11 | 4 | 90 | 4 | 10393440 | ||
| Pubmed | Localization of 20alpha-hydroxysteroid dehydrogenase mRNA in mouse brain by in situ hybridization. | 4.19e-11 | 4 | 90 | 4 | 15193432 | |
| Pubmed | Mouse Akr1cl gene product is a prostaglandin D2 11-ketoreductase with strict substrate specificity. | 4.19e-11 | 4 | 90 | 4 | 31479646 | |
| Pubmed | 4.19e-11 | 4 | 90 | 4 | 16191478 | ||
| Pubmed | 4.19e-11 | 4 | 90 | 4 | 15577209 | ||
| Pubmed | 4.19e-11 | 4 | 90 | 4 | 10702227 | ||
| Pubmed | 4.19e-11 | 4 | 90 | 4 | 17034817 | ||
| Pubmed | RECON-Dependent Inflammation in Hepatocytes Enhances Listeria monocytogenes Cell-to-Cell Spread. | 4.19e-11 | 4 | 90 | 4 | 29764944 | |
| Pubmed | 4.19e-11 | 4 | 90 | 4 | 17888864 | ||
| Pubmed | 4.19e-11 | 4 | 90 | 4 | 17442338 | ||
| Pubmed | 4.19e-11 | 4 | 90 | 4 | 28329705 | ||
| Pubmed | 4.19e-11 | 4 | 90 | 4 | 19237748 | ||
| Pubmed | 4.19e-11 | 4 | 90 | 4 | 28259989 | ||
| Pubmed | 4.19e-11 | 4 | 90 | 4 | 16511129 | ||
| Pubmed | 4.19e-11 | 4 | 90 | 4 | 7789999 | ||
| Pubmed | 4.19e-11 | 4 | 90 | 4 | 20124700 | ||
| Pubmed | Enzymatic properties of a member (AKR1C20) of the aldo-keto reductase family. | 4.19e-11 | 4 | 90 | 4 | 16508162 | |
| Pubmed | 4.19e-11 | 4 | 90 | 4 | 15222881 | ||
| Pubmed | 4.19e-11 | 4 | 90 | 4 | 17629694 | ||
| Pubmed | 4.19e-11 | 4 | 90 | 4 | 10526179 | ||
| Pubmed | 4.19e-11 | 4 | 90 | 4 | 16018803 | ||
| Pubmed | 4.19e-11 | 4 | 90 | 4 | 17272929 | ||
| Pubmed | Involvement of 20alpha-hydroxysteroid dehydrogenase in the maintenance of pregnancy in mice. | 4.19e-11 | 4 | 90 | 4 | 18667791 | |
| Pubmed | 4.19e-11 | 4 | 90 | 4 | 21521174 | ||
| Pubmed | 4.19e-11 | 4 | 90 | 4 | 8274401 | ||
| Pubmed | 4.19e-11 | 4 | 90 | 4 | 10803568 | ||
| Pubmed | AKR1C1 alleviates LPS‑induced ALI in mice by activating the JAK2/STAT3 signaling pathway. | 4.19e-11 | 4 | 90 | 4 | 34590152 | |
| Pubmed | Retinaldehyde is a substrate for human aldo-keto reductases of the 1C subfamily. | 2.09e-10 | 5 | 90 | 4 | 21851338 | |
| Pubmed | Characterization of brain neurons that express enzymes mediating neurosteroid biosynthesis. | 2.09e-10 | 5 | 90 | 4 | 16984997 | |
| Pubmed | 2.09e-10 | 5 | 90 | 4 | 7737980 | ||
| Pubmed | 2.09e-10 | 5 | 90 | 4 | 17872381 | ||
| Pubmed | Mouse 3alpha-hydroxysteroid dehydrogenase mRNA: a marker of lung maturity. | 2.09e-10 | 5 | 90 | 4 | 17064890 | |
| Pubmed | 2.09e-10 | 5 | 90 | 4 | 10672042 | ||
| Pubmed | 2.09e-10 | 5 | 90 | 4 | 38788959 | ||
| Pubmed | 2.09e-10 | 5 | 90 | 4 | 18003893 | ||
| Pubmed | 6.26e-10 | 6 | 90 | 4 | 19273550 | ||
| Pubmed | 6.26e-10 | 6 | 90 | 4 | 15471942 | ||
| Pubmed | MEF2 and NR2F2 cooperate to regulate Akr1c14 gene expression in mouse MA-10 Leydig cells. | 6.26e-10 | 6 | 90 | 4 | 26748576 | |
| Pubmed | The Gαq/11-provoked induction of Akr1c18 in murine luteal cells is mediated by phospholipase C. | 6.26e-10 | 6 | 90 | 4 | 29107092 | |
| Pubmed | 6.26e-10 | 6 | 90 | 4 | 15860270 | ||
| Pubmed | 6.26e-10 | 6 | 90 | 4 | 17122075 | ||
| Pubmed | Decidual prolactin silences the expression of genes detrimental to pregnancy. | 6.26e-10 | 6 | 90 | 4 | 17255200 | |
| Pubmed | ILF3 AP1B1 AP2B1 MTOR CIP2A PDS5A APPL1 PRKDC CDK1 API5 ZW10 ECPAS CNOT1 HELLS | 1.07e-09 | 638 | 90 | 14 | 33239621 | |
| Pubmed | 1.46e-09 | 7 | 90 | 4 | 22529366 | ||
| Pubmed | 1.46e-09 | 7 | 90 | 4 | 33127481 | ||
| Pubmed | 1.46e-09 | 7 | 90 | 4 | 12562828 | ||
| Pubmed | 1.46e-09 | 7 | 90 | 4 | 26160177 | ||
| Pubmed | Aldo-ketoreductase 1c19 ablation does not affect insulin secretion in murine islets. | 1.46e-09 | 7 | 90 | 4 | 34843575 | |
| Pubmed | 1.46e-09 | 7 | 90 | 4 | 16337335 | ||
| Pubmed | 2.91e-09 | 8 | 90 | 4 | 33584538 | ||
| Pubmed | 2.91e-09 | 8 | 90 | 4 | 9224647 | ||
| Pubmed | 2.91e-09 | 8 | 90 | 4 | 20837989 | ||
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 2.96e-09 | 202 | 90 | 9 | 33005030 | |
| Pubmed | 5.23e-09 | 9 | 90 | 4 | 33348080 | ||
| Pubmed | Lack of placental neurosteroid alters cortical development and female somatosensory function. | 8.70e-09 | 10 | 90 | 4 | 36313771 | |
| Pubmed | MRAP deficiency impairs adrenal progenitor cell differentiation and gland zonation. | 9.72e-09 | 28 | 90 | 5 | 29879378 | |
| Pubmed | 1.68e-08 | 3 | 90 | 3 | 19320734 | ||
| Pubmed | Aldo-keto reductases protect metastatic melanoma from ER stress-independent ferroptosis. | 1.68e-08 | 3 | 90 | 3 | 31780644 | |
| Pubmed | 1.68e-08 | 3 | 90 | 3 | 13678667 | ||
| Pubmed | 1.68e-08 | 3 | 90 | 3 | 7626489 | ||
| Pubmed | 1.68e-08 | 3 | 90 | 3 | 21232532 | ||
| Pubmed | 2.04e-08 | 12 | 90 | 4 | 25774556 | ||
| Pubmed | Endogenous biotin as a marker of adrenocortical cells with steroidogenic potential. | 2.04e-08 | 12 | 90 | 4 | 21256921 | |
| Pubmed | Timing of adrenal regression controlled by synergistic interaction between Sf1 SUMOylation and Dax1. | 2.04e-08 | 12 | 90 | 4 | 28893949 | |
| Pubmed | 2.94e-08 | 13 | 90 | 4 | 11682476 | ||
| Pubmed | A link between lung androgen metabolism and the emergence of mature epithelial type II cells. | 2.94e-08 | 13 | 90 | 4 | 15117747 | |
| Pubmed | 2.94e-08 | 13 | 90 | 4 | 24580729 | ||
| Pubmed | 2.94e-08 | 13 | 90 | 4 | 17062636 | ||
| Pubmed | 4.11e-08 | 14 | 90 | 4 | 19955443 | ||
| Pubmed | Placental endocrine function shapes cerebellar development and social behavior. | 4.11e-08 | 14 | 90 | 4 | 34400844 | |
| Pubmed | MED15 ILF3 AKR1C3 CPSF1 FARSB PDS5A PRKDC CDK1 API5 ECPAS AKR1C1 AKR1C2 PHC2 HELLS XPO7 | 5.03e-08 | 1014 | 90 | 15 | 32416067 | |
| Pubmed | 9.72e-08 | 17 | 90 | 4 | 32243503 | ||
| Pubmed | Functional dynamics of H3K9 methylation during meiotic prophase progression. | 1.58e-07 | 19 | 90 | 4 | 17599069 | |
| Pubmed | 1.67e-07 | 5 | 90 | 3 | 15212687 | ||
| Pubmed | 1.97e-07 | 20 | 90 | 4 | 24135228 | ||
| Pubmed | 1.97e-07 | 20 | 90 | 4 | 23636947 | ||
| Pubmed | 3.58e-07 | 23 | 90 | 4 | 23685333 | ||
| Pubmed | 5.09e-07 | 25 | 90 | 4 | 26098214 | ||
| Pubmed | 5.15e-07 | 183 | 90 | 7 | 23956138 | ||
| Pubmed | 5.82e-07 | 7 | 90 | 3 | 19846565 | ||
| Pubmed | Histone H3 lysine 9 methyltransferases, G9a and GLP are essential for cardiac morphogenesis. | 6.00e-07 | 26 | 90 | 4 | 23892084 | |
| Pubmed | 7.03e-07 | 27 | 90 | 4 | 17077188 | ||
| Pubmed | 7.03e-07 | 27 | 90 | 4 | 23471215 | ||
| Pubmed | Identification of differentially expressed genes in mouse spermatogenesis. | 7.03e-07 | 27 | 90 | 4 | 14581517 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | KNTC1 ILF3 TRIO DSP MTOR SYNE1 CPSF1 FARSB PDS5A PRKDC CDK1 API5 ECPAS DNAH5 CNOT1 HELLS | 7.12e-07 | 1425 | 90 | 16 | 30948266 |
| Pubmed | ILF3 AP2B1 TRIO CIP2A SVIL FARSB PDS5A RIOX1 CDK1 ECPAS XPO7 | 7.66e-07 | 634 | 90 | 11 | 34591612 | |
| Pubmed | The E3 ubiquitin ligase Siah1 regulates adrenal gland organization and aldosterone secretion. | 8.19e-07 | 28 | 90 | 4 | 29212953 | |
| Pubmed | 8.19e-07 | 28 | 90 | 4 | 21820362 | ||
| Pubmed | MED15 KNTC1 ILF3 AP1B1 AP2B1 FARSB C15orf39 PDS5A PRKDC CDK1 ZW10 ECPAS CNOT1 HELLS | 9.20e-07 | 1103 | 90 | 14 | 34189442 | |
| Pubmed | 1.08e-06 | 657 | 90 | 11 | 36180527 | ||
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | ILF3 AP1B1 AP2B1 DSP SYNE1 AKR1C3 PRKDC ECPAS CNOT1 AKR1C1 AKR1C2 VAV2 | 1.17e-06 | 807 | 90 | 12 | 30575818 |
| Pubmed | 1.43e-06 | 32 | 90 | 4 | 34288113 | ||
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | ILF3 AP1B1 AP2B1 DSP CIP2A SVIL FARSB PDS5A PRKDC CDK1 API5 ZW10 ECPAS CNOT1 | 1.49e-06 | 1149 | 90 | 14 | 35446349 |
| Pubmed | 2.03e-06 | 323 | 90 | 8 | 24797263 | ||
| Pubmed | Proteomic and yeast 2-hybrid screens to identify PTEN binding partners. | 2.11e-06 | 226 | 90 | 7 | 37839992 | |
| Pubmed | 2.59e-06 | 37 | 90 | 4 | 21362171 | ||
| Pubmed | TRIO PLEKHG4 INPP5B SYDE2 MCF2L2 CPSF1 PDS5A APPL1 API5 ECPAS PREX2 VAV2 | 4.32e-06 | 916 | 90 | 12 | 32203420 | |
| Interaction | C3orf18 interactions | 2.24e-09 | 115 | 90 | 9 | int:C3orf18 | |
| Interaction | SCN2B interactions | 1.02e-08 | 95 | 90 | 8 | int:SCN2B | |
| Interaction | FPR1 interactions | 1.95e-08 | 147 | 90 | 9 | int:FPR1 | |
| Interaction | AKR1C4 interactions | 2.57e-08 | 8 | 90 | 4 | int:AKR1C4 | |
| Interaction | GPR17 interactions | KNTC1 SACS MTOR CIP2A SPPL3 PDS5A PRKDC ZW10 ECPAS ITPR2 XPO7 | 5.37e-08 | 283 | 90 | 11 | int:GPR17 |
| Interaction | FAM234A interactions | 9.42e-08 | 126 | 90 | 8 | int:FAM234A | |
| Interaction | CHRM4 interactions | 2.09e-07 | 94 | 90 | 7 | int:CHRM4 | |
| Interaction | EED interactions | KNTC1 NPRL2 ILF3 CD6 AP2B1 TRIO DSP CIP2A SVIL MTTP CPSF1 FARSB PDS5A RIOX1 PRKDC CDK1 API5 ZW10 CNOT1 PHC2 HELLS XPO7 | 2.65e-07 | 1445 | 90 | 22 | int:EED |
| Interaction | LRRC31 interactions | 3.39e-07 | 205 | 90 | 9 | int:LRRC31 | |
| Interaction | CYB5B interactions | KNTC1 SLC16A2 MTOR CIP2A PDS5A TMEM35A ZW10 ECPAS HELLS XPO7 | 5.77e-07 | 285 | 90 | 10 | int:CYB5B |
| Interaction | MTTP interactions | 1.37e-06 | 19 | 90 | 4 | int:MTTP | |
| Interaction | CD80 interactions | 1.43e-06 | 79 | 90 | 6 | int:CD80 | |
| Interaction | AKR1C1 interactions | 1.71e-06 | 20 | 90 | 4 | int:AKR1C1 | |
| Interaction | OPALIN interactions | 4.38e-06 | 209 | 90 | 8 | int:OPALIN | |
| Interaction | GPR182 interactions | KNTC1 PLEKHG4 MTOR CIP2A SPPL3 PDS5A PRKDC ZW10 ECPAS HELLS XPO7 | 5.76e-06 | 455 | 90 | 11 | int:GPR182 |
| Interaction | P2RY10 interactions | 7.99e-06 | 106 | 90 | 6 | int:P2RY10 | |
| Interaction | GYPA interactions | 1.30e-05 | 174 | 90 | 7 | int:GYPA | |
| Interaction | AKR1C3 interactions | 2.19e-05 | 37 | 90 | 4 | int:AKR1C3 | |
| Interaction | EDNRB interactions | 2.71e-05 | 39 | 90 | 4 | int:EDNRB | |
| Interaction | NPTN interactions | 3.46e-05 | 278 | 90 | 8 | int:NPTN | |
| Interaction | SGO1 interactions | 3.59e-05 | 138 | 90 | 6 | int:SGO1 | |
| Interaction | STIP1 interactions | NPRL2 ILF3 AP1B1 AP2B1 MTOR CIP2A PDS5A APPL1 PRKDC CDK1 API5 ZW10 ECPAS CNOT1 HELLS | 3.65e-05 | 1006 | 90 | 15 | int:STIP1 |
| Interaction | HCST interactions | 3.72e-05 | 205 | 90 | 7 | int:HCST | |
| Interaction | RP2 interactions | 6.70e-05 | 95 | 90 | 5 | int:RP2 | |
| Interaction | PIP5K1C interactions | 7.32e-05 | 50 | 90 | 4 | int:PIP5K1C | |
| Interaction | FLT3 interactions | 8.88e-05 | 318 | 90 | 8 | int:FLT3 | |
| Interaction | CMKLR1 interactions | 8.97e-05 | 101 | 90 | 5 | int:CMKLR1 | |
| Interaction | EFNA4 interactions | 9.79e-05 | 239 | 90 | 7 | int:EFNA4 | |
| Interaction | AKR1C2 interactions | 1.07e-04 | 55 | 90 | 4 | int:AKR1C2 | |
| Interaction | SIGLECL1 interactions | 1.52e-04 | 113 | 90 | 5 | int:SIGLECL1 | |
| Interaction | NPY2R interactions | 2.17e-04 | 66 | 90 | 4 | int:NPY2R | |
| Interaction | EFNA5 interactions | 2.43e-04 | 68 | 90 | 4 | int:EFNA5 | |
| Interaction | CTDSPL2 interactions | 2.72e-04 | 70 | 90 | 4 | int:CTDSPL2 | |
| Interaction | COMTD1 interactions | 2.76e-04 | 200 | 90 | 6 | int:COMTD1 | |
| Cytoband | 10p15-p14 | 1.45e-07 | 6 | 90 | 3 | 10p15-p14 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr10p15 | 3.10e-05 | 90 | 90 | 4 | chr10p15 | |
| GeneFamily | Aldo-keto reductases | 1.66e-07 | 15 | 62 | 4 | 399 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 3.06e-06 | 66 | 62 | 5 | 722 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.53e-04 | 36 | 62 | 3 | 823 | |
| GeneFamily | Dyneins, axonemal | 1.52e-03 | 17 | 62 | 2 | 536 | |
| Coexpression | IRITANI_MAD1_TARGETS_UP | 2.99e-07 | 17 | 90 | 4 | MM826 | |
| Coexpression | VARELA_ZMPSTE24_TARGETS_DN | 4.68e-07 | 45 | 90 | 5 | MM1173 | |
| Coexpression | LIN_TUMOR_ESCAPE_FROM_IMMUNE_ATTACK | 1.31e-06 | 24 | 90 | 4 | MM766 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_DN | 1.56e-06 | 25 | 90 | 4 | MM480 | |
| Coexpression | MARSON_FOXP3_TARGETS_DN | 2.01e-06 | 60 | 90 | 5 | MM847 | |
| Coexpression | BYSTRYKH_HEMATOPOIESIS_STEM_CELL_SCP2_QTL_TRANS | 3.33e-06 | 30 | 90 | 4 | MM853 | |
| Coexpression | DESCARTES_ORGANOGENESIS_INTERMEDIATE_MESODERM | 7.04e-06 | 36 | 90 | 4 | MM3660 | |
| Coexpression | WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_UP | 7.87e-06 | 37 | 90 | 4 | MM630 | |
| Coexpression | ZAMORA_NOS2_TARGETS_DN | 1.41e-05 | 89 | 90 | 5 | MM690 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6 | 2.73e-05 | 102 | 90 | 5 | MM872 | |
| Coexpression | GAO_ESOPHAGUS_25W_C1_CILIATED_EPITHELIAL_CELLS | 2.89e-05 | 459 | 90 | 9 | M39136 | |
| Coexpression | KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP | KNTC1 DCDC2 ILF3 UBE2G2 ABCB10 TMTC3 FARSB PDS5A APPL1 PRKDC CDK1 ZW10 CNOT1 HELLS XPO7 | 3.15e-05 | 1290 | 90 | 15 | M80 |
| Coexpression | WOOD_EBV_EBNA1_TARGETS_UP | 3.93e-05 | 110 | 90 | 5 | M1696 | |
| Coexpression | NADLER_HYPERGLYCEMIA_AT_OBESITY | 7.96e-05 | 66 | 90 | 4 | MM631 | |
| Coexpression | PETROVA_PROX1_TARGETS_UP | 8.52e-05 | 25 | 90 | 3 | M1495 | |
| Coexpression | PATIL_LIVER_CANCER | 8.95e-05 | 660 | 90 | 10 | M1195 | |
| Coexpression | GOLDRATH_IMMUNE_MEMORY | 9.47e-05 | 69 | 90 | 4 | MM621 | |
| Coexpression | RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_UP | 1.10e-04 | 219 | 90 | 6 | MM1237 | |
| Coexpression | BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_UP | 1.24e-04 | 74 | 90 | 4 | MM769 | |
| Coexpression | SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM3 | 1.60e-04 | 79 | 90 | 4 | MM535 | |
| Coexpression | GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS | UBE2G2 AP1B1 TRIO SACS SLC16A2 COX16 SVIL FARSB APPL1 ZW10 HELLS XPO7 | 1.71e-04 | 1009 | 90 | 12 | M157 |
| Coexpression | HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_DN | 2.13e-04 | 85 | 90 | 4 | MM802 | |
| ToppCell | P07-Epithelial-airway_epithelial_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 9.58e-08 | 184 | 90 | 7 | a5e7af3392e9d6ddad0397f1eeb6b91ed1107cc2 | |
| ToppCell | P07-Epithelial-airway_epithelial_cell-club_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 9.58e-08 | 184 | 90 | 7 | ab469b9e06212462cbe2e4db8775c6778db855e6 | |
| ToppCell | P28-Epithelial-airway_epithelial_cell-club_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.03e-07 | 186 | 90 | 7 | a26811481668fa25c48a064a56c198685693ad8d | |
| ToppCell | P28-Epithelial-airway_epithelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.03e-07 | 186 | 90 | 7 | df80f101954b8ec6ccdb03e702de22e70b65181f | |
| ToppCell | facs-Lung-3m-Epithelial-airway_epithelial-lung_ciliated_cell-ciliated_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.23e-07 | 191 | 90 | 7 | 649fcb62ad15de2f83e61591e43923a717664ae7 | |
| ToppCell | facs-Lung-3m-Epithelial-airway_epithelial-lung_ciliated_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.23e-07 | 191 | 90 | 7 | 9621e22e14ea069f22713947c9faa2d882abe5fe | |
| ToppCell | facs-Lung-3m-Epithelial-airway_epithelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.23e-07 | 191 | 90 | 7 | 6a8fc9dc1a4c7115862e8f20204fa2f95e50e22f | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-10|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.32e-06 | 171 | 90 | 6 | 74be8d3bf6b99e2d734635a8b1a7c41e8c596959 | |
| ToppCell | P03-Epithelial-airway_epithelial_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.84e-06 | 181 | 90 | 6 | 1ea21d860d4d7abab3e21e130a16d044006656ee | |
| ToppCell | P03-Epithelial-airway_epithelial_cell-club_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.84e-06 | 181 | 90 | 6 | 60a91587c59029a34e7bec1255083337fe21b72a | |
| ToppCell | droplet-Lung-LUNG-30m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-06 | 183 | 90 | 6 | 3991830726d05cf19606d540de04093985b7bdeb | |
| ToppCell | droplet-Lung-LUNG-30m-Epithelial-Ciliated_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-06 | 183 | 90 | 6 | cc844f54c7564bf432b179ca63bc7c4b9b8cfdd9 | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-Ciliated_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.22e-06 | 187 | 90 | 6 | 04dba2ed09ee4180830bdf0191921696697ea234 | |
| ToppCell | P15-Epithelial-airway_epithelial_cell-club_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.22e-06 | 187 | 90 | 6 | a70aaae32426e9ddb1cbfbd0e0db24ccc96b9f40 | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.22e-06 | 187 | 90 | 6 | 805dafe22f835ece4dd091d8030d0a63b52a48dd | |
| ToppCell | P15-Epithelial-airway_epithelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.29e-06 | 188 | 90 | 6 | e3e71c0f2e374330620cb4d27638953ffa9f5298 | |
| ToppCell | facs-Lung-18m-Epithelial-airway_epithelial-lung_ciliated_cell-ciliated_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.43e-06 | 190 | 90 | 6 | 9ffd18ef358f8e32c610ab6420f479067c8ba44b | |
| ToppCell | facs-Lung-18m-Epithelial-airway_epithelial-lung_ciliated_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.43e-06 | 190 | 90 | 6 | 3ef39d61c98de4e5df946b995847aa65eba6a4b6 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.51e-06 | 191 | 90 | 6 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.51e-06 | 191 | 90 | 6 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | Ciliated-cil-3|World / Class top | 2.58e-06 | 192 | 90 | 6 | 4989ebb8812b8af1870599acd932849122c05a29 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.66e-06 | 193 | 90 | 6 | b25cdca3a1e381784ae48ca73c51cbb6ac62b811 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.66e-06 | 193 | 90 | 6 | 3f8280ef849d95b2fcea5e6824b95a07febc96d0 | |
| ToppCell | (05)_Ciliated|World / shred by cell type and Timepoint | 2.99e-06 | 197 | 90 | 6 | fee3cd16af8eea697cd64e8f64af505aaa2ac4b0 | |
| ToppCell | LPS_anti-TNF-Epithelial_airway-airway_epithelial-Airway-Club|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.08e-06 | 198 | 90 | 6 | 6712216c5a7fd86b68fd45b0ff7794975f19774e | |
| ToppCell | LPS_anti-TNF-Epithelial_airway-airway_epithelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.17e-06 | 199 | 90 | 6 | 60919c2af31d39a2d36d7bc432e43dab2a4e05fb | |
| ToppCell | LPS_anti-TNF-Epithelial_airway|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.17e-06 | 199 | 90 | 6 | 6aca164bbbb961f34b1e6f1857f91ade5c059405 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.27e-06 | 200 | 90 | 6 | 52aef65f01b06cd98056f17977efe525aee6eb6f | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.27e-06 | 200 | 90 | 6 | 55c148238d5c80c1faa3428a917ae8075be2c145 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal-Cilia-bearing_cell|6m / Sample Type, Dataset, Time_group, and Cell type. | 3.27e-06 | 200 | 90 | 6 | 177f9ad8dd8635394c575a2b30140184df0bd51e | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-epithelial_progenitor_cell-Proximal_progenitor|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.54e-06 | 114 | 90 | 5 | b350140b389f8762c77a37df473081e1127a8972 | |
| ToppCell | LPS-IL1RA-Epithelial_airway-Ciliated_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.39e-05 | 151 | 90 | 5 | 81cf939ed4df9574fbfff265e109cb9f947d7e6e | |
| ToppCell | LPS-IL1RA-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.39e-05 | 151 | 90 | 5 | 9cbcbbc22965a9f0be8364e733d205dd64f2a533 | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells-Ciliated|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.53e-05 | 154 | 90 | 5 | 4e3bc24043144143842627cacf6f90dda2228910 | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.53e-05 | 154 | 90 | 5 | 7556a4b2b062da5ae7ec2bbb66e745e7662db628 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.58e-05 | 155 | 90 | 5 | 5f1e2195a6b831e1b636f5cc3a282ca423721822 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.58e-05 | 155 | 90 | 5 | 0944429459f642a1bcc56edc1ec28aaecde3e2dc | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.07e-05 | 164 | 90 | 5 | c5bfae7e9497185548c243d6f9ebadbcef48ba7f | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)-Goblet_(bronchial)_L.0.4.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.07e-05 | 164 | 90 | 5 | 76b0ac220b7ca22fbea28a507f01f96ae9f53932 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.07e-05 | 164 | 90 | 5 | 911081739174ec68bc0893c804e4276b206bea7d | |
| ToppCell | LPS_only-Epithelial_airway|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.07e-05 | 164 | 90 | 5 | 56e6934e6c7503a300d7be06762d45a1d6f1ae0f | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-Klrb1a/b/c(-)_NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.13e-05 | 165 | 90 | 5 | eeb58d4db64ad37dc6b441eab22b05c24862e1a9 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.13e-05 | 165 | 90 | 5 | 62457b7b74c6eae42d91d65e7dc6df6bf8e061f7 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-T_cells-Th1|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.26e-05 | 167 | 90 | 5 | 9c55ec8f70b86d4d3d5c2a6ecd9bff2dafe68c11 | |
| ToppCell | droplet-Fat-Gat-18m-Epithelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.68e-05 | 173 | 90 | 5 | f3f67531f72d6d52e19c7f1f2db1ab4026fb70da | |
| ToppCell | droplet-Fat-Gat-18m-Epithelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.68e-05 | 173 | 90 | 5 | a40a52d8041d45dc3bef74fe55945ae07aa018d6 | |
| ToppCell | droplet-Fat-Gat-18m-Epithelial-epithelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.68e-05 | 173 | 90 | 5 | f0b4dd1cf41d6ee6abb0e1968b8b39f4fabebcb5 | |
| ToppCell | facs-Trachea-nan-18m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.91e-05 | 176 | 90 | 5 | ed788a5969edfd1199828ca5b0dd34e7f29c4d30 | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-actively_dividing_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.99e-05 | 177 | 90 | 5 | 8a0f0fbb06cdacb99a3fdba0da3e0494b891db4f | |
| ToppCell | droplet-Lung-LUNG-30m-Epithelial-club_cell_of_bronchiole|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.99e-05 | 177 | 90 | 5 | 7ac99ff16df94b4e08d361e3d98a7b3af8d6ee3b | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.99e-05 | 177 | 90 | 5 | e9d7682517fb30fd2ad535d59779d718a7024c13 | |
| ToppCell | droplet-Lung-21m-Epithelial-airway_epithelial-lung_ciliated_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.99e-05 | 177 | 90 | 5 | d947ba38db1772fc5fdcdc211f7511c4aa699dee | |
| ToppCell | droplet-Lung-LUNG-30m-Epithelial-Club_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.99e-05 | 177 | 90 | 5 | 092a345cb802f183322aa5542341ba2d96d4f06a | |
| ToppCell | droplet-Lung-21m-Epithelial-airway_epithelial-lung_ciliated_cell-ciliated_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.99e-05 | 177 | 90 | 5 | d5640f0097878f0dac671e51dc51310278bb2682 | |
| ToppCell | facs-Trachea-18m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell-ciliated_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.15e-05 | 179 | 90 | 5 | d4efbc34f52136039b96451fd0b0a0ad164197c6 | |
| ToppCell | facs-Trachea-18m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.15e-05 | 179 | 90 | 5 | 8a66d197a2f55d763ff7ef0bec89ee96f59c3937 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.15e-05 | 179 | 90 | 5 | 88d44b04eb5c079531db663ed98ddb20b60feb9a | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.59e-05 | 184 | 90 | 5 | 797b6a6d6f6aafae98f75ca8bffe8263f8d3ff9b | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.59e-05 | 184 | 90 | 5 | 77d5b60a20b277f589b18f7a131142a7ef2dac17 | |
| ToppCell | Control-Myeloid-Macrophage_Alveolar|World / Disease state, Lineage and Cell class | 3.69e-05 | 185 | 90 | 5 | 85cb81759589a26d83676cffbf2bc37399683c10 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.69e-05 | 185 | 90 | 5 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | 15-Airway-Epithelial-Multiciliated_cell|Airway / Age, Tissue, Lineage and Cell class | 3.69e-05 | 185 | 90 | 5 | 0998b6bf44287eebbf39249fff23fc3689e44c4e | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.78e-05 | 186 | 90 | 5 | 76033438426d8f9c72cd6691a7baf92104c9f03d | |
| ToppCell | droplet-Lung-nan-18m-Epithelial-Ciliated_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.78e-05 | 186 | 90 | 5 | 740fd06bcd3b24e6ff2ecf8080f378afc3e95084 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-Tuft-related-Microfold_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.78e-05 | 186 | 90 | 5 | 6d8dd6d0403d149cb6edb346581fe6c248036785 | |
| ToppCell | droplet-Lung-nan-18m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.78e-05 | 186 | 90 | 5 | 5ab43a298d23238b34e898d11decf0ad81d1b14e | |
| ToppCell | facs-MAT-Fat-3m-Epithelial-nan|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.82e-05 | 93 | 90 | 4 | dbfaa7f23d25f5c286ab7ca3ca795b734cb95153 | |
| ToppCell | facs-MAT-Fat-3m-Epithelial-epithelial_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.82e-05 | 93 | 90 | 4 | 0d6d1d8dd9c91ba31eb35a4b5979d087890936c1 | |
| ToppCell | facs-MAT-Fat-3m-Epithelial|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.82e-05 | 93 | 90 | 4 | abffb1fd5a919b7c08e62e1c3c08a8dd8783a4ca | |
| ToppCell | droplet-Lung-3m-Epithelial-airway_epithelial-lung_ciliated_cell-ciliated_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.88e-05 | 187 | 90 | 5 | 1bba994aaaa9825b54aaeaff3829850267bc4602 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.88e-05 | 187 | 90 | 5 | 73931a5ea73799095daff100b5f18853c57c74dc | |
| ToppCell | droplet-Lung-3m-Epithelial-airway_epithelial-lung_ciliated_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.88e-05 | 187 | 90 | 5 | d6ac351e7aeba98851d308c14ac395044fe4fbbb | |
| ToppCell | droplet-Lung-18m-Epithelial-airway_epithelial-lung_ciliated_cell-ciliated_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.98e-05 | 188 | 90 | 5 | 0eca3dc93724e23b71e687fc24fa9f1e89bdef6a | |
| ToppCell | droplet-Lung-18m-Epithelial-airway_epithelial-lung_ciliated_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.98e-05 | 188 | 90 | 5 | 9ce3e1fffce87ad19812ecbf9b7f9935a975d676 | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.08e-05 | 189 | 90 | 5 | 057d7a03fdbe779122b203619a6f947f49b84d28 | |
| ToppCell | PND01-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.08e-05 | 189 | 90 | 5 | b55de812043b670cbde810d7d42f45909b6d66ef | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.08e-05 | 189 | 90 | 5 | 02c6128a9ab5818e0881dcadafdad5f08b9a67cf | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.08e-05 | 189 | 90 | 5 | 164ea92ff6a1aa2ead1c9b8f64f99a9d65437232 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.08e-05 | 189 | 90 | 5 | 8c8ca3b30d9be6c854615459a7bfba82b427c8bc | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.08e-05 | 189 | 90 | 5 | 9f57a131902d23494bf389baf6e6e2d99f88b2c8 | |
| ToppCell | droplet-Lung-18m-Epithelial-airway_epithelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.08e-05 | 189 | 90 | 5 | fe958fdf9963c2dfe270f67f0da36b3264d0017c | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.08e-05 | 189 | 90 | 5 | 5d902a4660a27548764bf04c6de152b565da835c | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.08e-05 | 189 | 90 | 5 | a85099bd598a27ee64ee0664d051d89fa8d62fc9 | |
| ToppCell | COVID-19-lung-Ciliated|lung / Disease (COVID-19 only), tissue and cell type | 4.08e-05 | 189 | 90 | 5 | 27329c4661aebabd19fac7fe5dca263fe99d76f3 | |
| ToppCell | PND01-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.08e-05 | 189 | 90 | 5 | 4e83e49d1265ffe507fdb72924c77c4d1c73f0bd | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.08e-05 | 189 | 90 | 5 | e443b02502edaefa94567a9e8af5756e8e11ff30 | |
| ToppCell | facs-Lung-nan-3m-Epithelial-Ciliated_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.19e-05 | 190 | 90 | 5 | e243b5fbb17b9ec3cc90bbe970c1d30b0fd1c2e1 | |
| ToppCell | droplet-Lung-30m-Hematologic-lymphocytic-Proliferating_T_cell-proliferating_T|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.19e-05 | 190 | 90 | 5 | f5a8b44d9948a16e2d5284c78d8f7ed422ac623a | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.19e-05 | 190 | 90 | 5 | a5db902ad112a0c0a0a7f1a2e38718bb3bd11412 | |
| ToppCell | facs-Lung-nan-3m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.19e-05 | 190 | 90 | 5 | fe844559b95832845d2e8d3ab4b57e3d558bc372 | |
| ToppCell | droplet-Lung-30m-Hematologic-lymphocytic-Proliferating_T_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.19e-05 | 190 | 90 | 5 | 08420f0ecd2c62e102371d16dcb8eda0d510e92a | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.29e-05 | 191 | 90 | 5 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| ToppCell | COVID-19-kidney-Proliferating_T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.29e-05 | 191 | 90 | 5 | bae388e0e9447d576e68465d73d8313ef6925ffa | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.29e-05 | 191 | 90 | 5 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.51e-05 | 193 | 90 | 5 | b38aaffbea36ef6c08ebe82675438f873c89b242 | |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 4.51e-05 | 193 | 90 | 5 | ad58f5080e0ba65c845056ea6b79037b636e9c64 | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.62e-05 | 194 | 90 | 5 | 663e7e7fe48157e808b4f1a0ea6ad41944e857a2 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.62e-05 | 194 | 90 | 5 | f95c8dc242c9aebcadfe61b1ed033349cb7e5a88 | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 4.74e-05 | 195 | 90 | 5 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.74e-05 | 195 | 90 | 5 | cec7df321f372d05c94f97d6bb18891a5cc3dec3 | |
| Drug | cloxazolam | 2.28e-10 | 4 | 90 | 4 | ctd:C005522 | |
| Drug | Pregnanes | 2.28e-10 | 4 | 90 | 4 | ctd:D011278 | |
| Drug | tetralol | 2.28e-10 | 4 | 90 | 4 | ctd:C019106 | |
| Drug | 3',3'',5',5''-tetrabromophenolphthalein | 2.28e-10 | 4 | 90 | 4 | ctd:C018156 | |
| Drug | Hydroxysteroids | 1.14e-09 | 5 | 90 | 4 | ctd:D006914 | |
| Drug | cresolphthalein | 1.14e-09 | 5 | 90 | 4 | ctd:C010092 | |
| Drug | Meclofenamic Acid | 1.68e-09 | 14 | 90 | 5 | ctd:D008469 | |
| Drug | Medazepam | 3.40e-09 | 6 | 90 | 4 | ctd:D008472 | |
| Drug | Nitrazepam | 1.58e-08 | 8 | 90 | 4 | ctd:D009567 | |
| Drug | 4-hydroxybenzoic acid | 2.83e-08 | 9 | 90 | 4 | ctd:C038193 | |
| Drug | 20-alpha-Dihydroprogesterone | 2.83e-08 | 9 | 90 | 4 | ctd:D004092 | |
| Drug | octyl gallate | 4.71e-08 | 10 | 90 | 4 | ctd:C016627 | |
| Drug | cyclopentanol | 5.97e-08 | 3 | 90 | 3 | ctd:C016327 | |
| Drug | cyclopentanone | 5.97e-08 | 3 | 90 | 3 | ctd:C007201 | |
| Drug | 5-dihydrodeoxycorticosterone | 5.97e-08 | 3 | 90 | 3 | ctd:C454687 | |
| Drug | 4-benzoylbenzoic acid | 5.97e-08 | 3 | 90 | 3 | ctd:C058818 | |
| Drug | dichloro(4-cymene)ruthenium(II) | 5.97e-08 | 3 | 90 | 3 | ctd:C530610 | |
| Drug | Dihydroxydihydrobenzopyrenes | 7.38e-08 | 11 | 90 | 4 | ctd:D004101 | |
| Drug | chlordecone alcohol | 7.38e-08 | 11 | 90 | 4 | CID000013946 | |
| Drug | Phenolphthalein | 1.10e-07 | 12 | 90 | 4 | ctd:D020113 | |
| Drug | DMBA-3,4-dihydrodiol | 1.59e-07 | 13 | 90 | 4 | CID000050096 | |
| Drug | flunisolide | 1.59e-07 | 13 | 90 | 4 | ctd:C007734 | |
| Drug | 5-alpha-Dihydroprogesterone | 2.22e-07 | 14 | 90 | 4 | ctd:D043582 | |
| Drug | 1-acenaphthenol | 2.22e-07 | 14 | 90 | 4 | CID000022750 | |
| Drug | tetrahydrodeoxycorticosterone | 2.38e-07 | 4 | 90 | 3 | ctd:C009413 | |
| Drug | gliquidone | 2.38e-07 | 4 | 90 | 3 | ctd:C010969 | |
| Drug | DBD-H | 2.38e-07 | 4 | 90 | 3 | CID000131382 | |
| Drug | NSC86000 | 5.94e-07 | 5 | 90 | 3 | CID000257630 | |
| Drug | oxcarbazepine | 8.46e-07 | 19 | 90 | 4 | ctd:C036006 | |
| Drug | benzo(a)pyrene-7,8-dione | 1.05e-06 | 20 | 90 | 4 | ctd:C076588 | |
| Drug | Chrysenes | 1.05e-06 | 20 | 90 | 4 | ctd:D002911 | |
| Drug | AC1L93E5 | 1.18e-06 | 6 | 90 | 3 | CID000412383 | |
| Drug | Estazolam | 1.18e-06 | 6 | 90 | 3 | ctd:D004949 | |
| Drug | 3-hydroxyhexobarbital | 1.18e-06 | 6 | 90 | 3 | CID000439898 | |
| Drug | Glipizide | 1.18e-06 | 6 | 90 | 3 | ctd:D005913 | |
| Drug | acenaphthene-1-ol | 1.18e-06 | 6 | 90 | 3 | ctd:C023723 | |
| Drug | Flunitrazepam | 1.30e-06 | 21 | 90 | 4 | ctd:D005445 | |
| Drug | benzene dihydrodiol | 1.58e-06 | 22 | 90 | 4 | CID000000418 | |
| Drug | 4-hydroxyequilenin-o-quinone | 2.07e-06 | 7 | 90 | 3 | ctd:C117714 | |
| Drug | zomepirac | 2.07e-06 | 7 | 90 | 3 | ctd:C020549 | |
| Drug | Glycyrrhetinic Acid | 2.28e-06 | 24 | 90 | 4 | ctd:D006034 | |
| Drug | Hexestrol | 2.57e-06 | 55 | 90 | 5 | ctd:D006589 | |
| Drug | 9,10-phenanthrenequinone | 2.71e-06 | 25 | 90 | 4 | ctd:C005399 | |
| Drug | Pregnanolone | 2.71e-06 | 25 | 90 | 4 | ctd:D011280 | |
| Drug | 2-cyclohexen-1-ol | 3.30e-06 | 8 | 90 | 3 | CID000013198 | |
| Drug | benzo(a)pyrene 7,8-dihydrodiol | 6.62e-06 | 31 | 90 | 4 | ctd:C017228 | |
| Drug | fenamic acid | 1.28e-05 | 12 | 90 | 3 | ctd:C001209 | |
| Drug | DB07444 | 1.28e-05 | 12 | 90 | 3 | CID006540255 | |
| Drug | Sotalol hydrochloride [959-24-0]; Down 200; 13uM; MCF7; HT_HG-U133A | 1.42e-05 | 199 | 90 | 7 | 7338_DN | |
| Drug | alpha-methylcinnamic acid | 1.55e-05 | 2 | 90 | 2 | ctd:C510582 | |
| Drug | (10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE | 1.55e-05 | 2 | 90 | 2 | DB07768 | |
| Drug | baccharin | 1.55e-05 | 2 | 90 | 2 | ctd:C012764 | |
| Drug | 4-formyl-benzoate | 1.66e-05 | 13 | 90 | 3 | CID000012088 | |
| Drug | 20 alpha-dihydroprogesterone | 1.87e-05 | 40 | 90 | 4 | CID000008956 | |
| Drug | aa 2 | 2.07e-05 | 41 | 90 | 4 | CID000447622 | |
| Drug | o-quinone | 2.07e-05 | 41 | 90 | 4 | CID000011421 | |
| Drug | Dydrogesterone | 2.11e-05 | 14 | 90 | 3 | ctd:D004394 | |
| Drug | 6-.beta.-Naltrexol | 2.11e-05 | 14 | 90 | 3 | CID000631219 | |
| Drug | androsterone glucuronide | 2.50e-05 | 43 | 90 | 4 | CID000114833 | |
| Drug | drospirenone | 2.63e-05 | 15 | 90 | 3 | ctd:C035144 | |
| Drug | Flufenamic Acid | 3.00e-05 | 45 | 90 | 4 | ctd:D005439 | |
| Drug | naphthalene-1,2-dihydrodiol | 3.00e-05 | 45 | 90 | 4 | CID000000362 | |
| Drug | 9-cis-retinal | 3.22e-05 | 16 | 90 | 3 | ctd:C031390 | |
| Drug | benzo(a)pyrene-1,6-quinone | 3.90e-05 | 17 | 90 | 3 | ctd:C030233 | |
| Drug | XK469 | 3.90e-05 | 17 | 90 | 3 | CID000148183 | |
| Drug | NSC55 | 4.62e-05 | 3 | 90 | 2 | CID000012116 | |
| Drug | cloxazolam | 4.67e-05 | 18 | 90 | 3 | CID000002816 | |
| Drug | Ruthenium Compounds | 4.67e-05 | 18 | 90 | 3 | ctd:D017975 | |
| Drug | benzo(a)pyrene-3,6-quinone | 4.67e-05 | 18 | 90 | 3 | ctd:C018003 | |
| Drug | 1 C2 | 4.83e-05 | 100 | 90 | 5 | CID005327152 | |
| Drug | androstane-3,17-dione | 4.95e-05 | 51 | 90 | 4 | CID000000443 | |
| Drug | 3-hydroxyandrostan-17-one | 5.31e-05 | 102 | 90 | 5 | CID000000225 | |
| Drug | AC1L8ZBW | 5.53e-05 | 19 | 90 | 3 | CID000435356 | |
| Drug | coniferaldehyde | 7.54e-05 | 21 | 90 | 3 | ctd:C075384 | |
| Drug | Dutasteride | 7.54e-05 | 21 | 90 | 3 | ctd:D000068538 | |
| Drug | 1,2-dihydroxynaphthalene | 7.68e-05 | 57 | 90 | 4 | CID000011318 | |
| Drug | phenolphthalein | 8.23e-05 | 58 | 90 | 4 | CID000004764 | |
| Drug | NSC36919 | 8.23e-05 | 58 | 90 | 4 | CID000235496 | |
| Drug | methiin | 9.22e-05 | 4 | 90 | 2 | CID000082142 | |
| Drug | gamma-terpineol | 9.22e-05 | 4 | 90 | 2 | CID000011467 | |
| Drug | Sanguinarine [2447-54-3]; Down 200; 12uM; HL60; HT_HG-U133A | 9.38e-05 | 185 | 90 | 6 | 2927_DN | |
| Drug | 2-carboxybenzaldehyde | 9.99e-05 | 23 | 90 | 3 | CID000008406 | |
| Drug | 2'-Monophosphoadenosine 5'-Diphosphoribose | 9.99e-05 | 23 | 90 | 3 | DB03461 | |
| Drug | 9,10-phenanthrenequinone | 1.00e-04 | 61 | 90 | 4 | CID000006763 | |
| Drug | medazepam | 1.14e-04 | 24 | 90 | 3 | CID000004041 | |
| Drug | Ceforanide [60925-61-3]; Down 200; 7.6uM; PC3; HT_HG-U133A | 1.18e-04 | 193 | 90 | 6 | 6751_DN | |
| Drug | isoeugenol | 1.21e-04 | 64 | 90 | 4 | ctd:C036643 | |
| Drug | Midodrine hydrochloride [3092-17-9]; Down 200; 13.8uM; PC3; HT_HG-U133A | 1.22e-04 | 194 | 90 | 6 | 2087_DN | |
| Drug | Neostigmine bromide [114-80-7]; Up 200; 13.2uM; MCF7; HT_HG-U133A | 1.25e-04 | 195 | 90 | 6 | 3294_UP | |
| Drug | Sulmazole [73384-60-8]; Up 200; 14uM; MCF7; HT_HG-U133A | 1.29e-04 | 196 | 90 | 6 | 4127_UP | |
| Drug | Dequalinium dichloride [522-51-0]; Up 200; 7.6uM; MCF7; HT_HG-U133A | 1.29e-04 | 196 | 90 | 6 | 2631_UP | |
| Drug | Clorsulon [60200-06-8]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 1.29e-04 | 196 | 90 | 6 | 2884_UP | |
| Drug | R(+)-verapamil hydrochloride; Down 200; 10uM; MCF7; HG-U133A | 1.32e-04 | 197 | 90 | 6 | 164_DN | |
| Drug | Aceclofenac [89796-99-6]; Up 200; 11.2uM; PC3; HT_HG-U133A | 1.32e-04 | 197 | 90 | 6 | 2117_UP | |
| Drug | Lomefloxacin hydrochloride [98079-52-8]; Down 200; 10.4uM; PC3; HT_HG-U133A | 1.32e-04 | 197 | 90 | 6 | 3723_DN | |
| Drug | Isradipine [75695-93-1]; Up 200; 10.8uM; PC3; HT_HG-U133A | 1.36e-04 | 198 | 90 | 6 | 6347_UP | |
| Drug | tamoxifen citrate; Down 200; 1uM; MCF7; HG-U133A | 1.40e-04 | 199 | 90 | 6 | 380_DN | |
| Drug | chlordecone | 1.45e-04 | 67 | 90 | 4 | CID000000299 | |
| Drug | glycolithocholic acid | 1.45e-04 | 26 | 90 | 3 | CID000115245 | |
| Drug | V-X-R | 1.53e-04 | 5 | 90 | 2 | CID011957413 | |
| Disease | Neoplasms, Hormone-Dependent | 2.74e-08 | 3 | 90 | 3 | C0027661 | |
| Disease | Hermaphroditism | 2.73e-07 | 5 | 90 | 3 | C0019269 | |
| Disease | Ambiguous Genitalia | 2.73e-07 | 5 | 90 | 3 | C0266362 | |
| Disease | Pseudohermaphroditism | 2.73e-07 | 5 | 90 | 3 | C0033804 | |
| Disease | Intersex Conditions | 2.73e-07 | 5 | 90 | 3 | C2930618 | |
| Disease | Sex Differentiation Disorders | 2.73e-07 | 5 | 90 | 3 | C2930619 | |
| Disease | Disorders of Sex Development | 9.52e-07 | 7 | 90 | 3 | C0036875 | |
| Disease | MALE PSEUDOHERMAPHRODITISM: DEFICIENCY OF TESTICULAR 17,20-DESMOLASE | 9.20e-06 | 2 | 90 | 2 | C1839840 | |
| Disease | 46,XY disorder of sex development due to testicular 17,20-desmolase deficiency | 9.20e-06 | 2 | 90 | 2 | cv:C1839840 | |
| Disease | 46,XY sex reversal 8 (is_implicated_in) | 9.20e-06 | 2 | 90 | 2 | DOID:0111773 (is_implicated_in) | |
| Disease | 46,XY SEX REVERSAL 8 | 9.20e-06 | 2 | 90 | 2 | 614279 | |
| Disease | Kartagener syndrome (implicated_via_orthology) | 9.75e-06 | 14 | 90 | 3 | DOID:0050144 (implicated_via_orthology) | |
| Disease | Kartagener syndrome (is_implicated_in) | 5.50e-05 | 4 | 90 | 2 | DOID:0050144 (is_implicated_in) | |
| Disease | phosphatidylcholine 38:4 measurement | 8.51e-05 | 28 | 90 | 3 | EFO_0010386 | |
| Disease | response to bevacizumab, Proteinuria | 9.15e-05 | 5 | 90 | 2 | EFO_0005943, HP_0000093 | |
| Disease | procollagen C-endopeptidase enhancer 1 measurement | 1.37e-04 | 6 | 90 | 2 | EFO_0801920 | |
| Disease | cortolone glucuronide (1) measurement | 1.37e-04 | 6 | 90 | 2 | EFO_0800552 | |
| Disease | visceral heterotaxy (implicated_via_orthology) | 1.98e-04 | 37 | 90 | 3 | DOID:0050545 (implicated_via_orthology) | |
| Disease | chemotherapy-induced alopecia, methylcobalamin deficiency type cblE | 2.55e-04 | 8 | 90 | 2 | EFO_0005400, MONDO_0009354 | |
| Disease | alcohol consumption measurement | NDST3 MTOR KCNJ3 MTTP FARSB ADGRV1 ZW10 DNAH5 BTBD3 PHC2 CCDC33 XPO7 | 3.88e-04 | 1242 | 90 | 12 | EFO_0007878 |
| Disease | Intellectual Disability | 4.43e-04 | 447 | 90 | 7 | C3714756 | |
| Disease | Metastatic melanoma | 6.08e-04 | 54 | 90 | 3 | C0278883 | |
| Disease | Sclerocystic Ovaries | 1.00e-03 | 144 | 90 | 4 | C1136382 | |
| Disease | Polycystic Ovary Syndrome | 1.00e-03 | 144 | 90 | 4 | C0032460 | |
| Disease | maximal oxygen uptake measurement, response to exercise | 1.07e-03 | 16 | 90 | 2 | EFO_0004887, EFO_0007768 | |
| Disease | response to methotrexate | 1.07e-03 | 16 | 90 | 2 | GO_0031427 | |
| Disease | Colorectal Carcinoma | 1.38e-03 | 702 | 90 | 8 | C0009402 | |
| Disease | cytochrome-c oxidase deficiency disease (is_implicated_in) | 1.52e-03 | 19 | 90 | 2 | DOID:3762 (is_implicated_in) | |
| Disease | primary ciliary dyskinesia (implicated_via_orthology) | 1.52e-03 | 19 | 90 | 2 | DOID:9562 (implicated_via_orthology) | |
| Disease | selenium measurement, response to dietary selenium supplementation | 1.69e-03 | 20 | 90 | 2 | EFO_0006331, EFO_0600021 | |
| Disease | Lung diseases | 1.77e-03 | 78 | 90 | 3 | C0024115 | |
| Disease | Nonsyndromic Deafness | 1.97e-03 | 81 | 90 | 3 | C3711374 | |
| Disease | Bronchiectasis | 2.04e-03 | 22 | 90 | 2 | C0006267 | |
| Disease | triacylglycerol 54:8 measurement | 2.23e-03 | 23 | 90 | 2 | EFO_0010426 | |
| Disease | Dyslipidemias | 2.43e-03 | 24 | 90 | 2 | C0242339 | |
| Disease | childhood trauma measurement | 2.43e-03 | 24 | 90 | 2 | EFO_0007979 | |
| Disease | Dyslipoproteinemias | 2.43e-03 | 24 | 90 | 2 | C0598784 | |
| Disease | forced expiratory volume, response to bronchodilator | 2.44e-03 | 445 | 90 | 6 | EFO_0004314, GO_0097366 | |
| Disease | Liver Cirrhosis, Experimental | 2.53e-03 | 774 | 90 | 8 | C0023893 | |
| Disease | diacylglycerol 34:2 measurement | 2.64e-03 | 25 | 90 | 2 | EFO_0010353 | |
| Disease | response to norepinephrine-dopamine reuptake inhibitor | 2.85e-03 | 26 | 90 | 2 | EFO_0007870 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RQLEMILNKPGLKYK | 171 | P17516 | |
| RILSDLNLVMYPKLG | 271 | Q96KX2 | |
| ANLDRLIPMYKGAKI | 1026 | Q8NHU2 | |
| PIYVKLEKLDIMIRL | 331 | P63010 | |
| VLPLKSRLYQKMLTG | 516 | Q8N5R6 | |
| VAPLMKYLDEKLALL | 891 | O94812 | |
| RQLEMILNKPGLKYK | 171 | P42330 | |
| MAKLLSCVLGPRLYK | 1 | O95870 | |
| IIRLKGLMGKVLVSY | 2001 | Q8WXG9 | |
| IVLSMLLLRRKKPYG | 596 | P51693 | |
| MKLQVYDLPGILARL | 146 | Q12887 | |
| RLRYFMELLLEKGKP | 2491 | Q96DT5 | |
| EELLSKPNGIYRKLM | 716 | Q9NRK6 | |
| KVLGKALYLIRIPTM | 311 | Q9Y2F9 | |
| NLRKLFDKLLEYMPL | 306 | Q9BZZ5 | |
| PIYVKLEKLDIMIRL | 331 | Q10567 | |
| RKNKTLGYGVPMLLL | 11 | Q9P0S2 | |
| LMLPATVLLYRKLGI | 1076 | A7MBM2 | |
| MLLPYLRKKLRLTGT | 26 | Q06278 | |
| FPFLIRMLGDKIKLA | 246 | P36021 | |
| DLPVLIDKMKGKYIL | 116 | O95803 | |
| LHKALVKLLLPLEYM | 936 | Q29RF7 | |
| INPLGKYRMDLVLQL | 2026 | Q14571 | |
| FILLRIKGKYALPVM | 421 | P30203 | |
| FLILDRMLPELKKRG | 601 | Q9NRZ9 | |
| FLLLLKELLNPIYGM | 751 | Q15034 | |
| LGIVMDKYGPRKLRL | 106 | Q8N370 | |
| KKKIALLEPLLGYMQ | 191 | Q9UKG1 | |
| GLLLPMQEKTYRRLL | 1346 | Q10570 | |
| PMLLNGLTKLINEYK | 396 | Q5VYK3 | |
| SQRLIKYQMLLKGLL | 756 | Q86YR7 | |
| RMYLLALKNALLPEG | 471 | P55157 | |
| LLRLFVKLPEILGKM | 456 | Q8N5Y2 | |
| LKQLSKYIEPLRRMI | 536 | Q96RN5 | |
| LLGFNMIPYLRKVLK | 1986 | P50748 | |
| LIGPRYKLRILRMKL | 401 | Q8WWY8 | |
| LELLLMNRYVKPGLK | 191 | Q8WVL7 | |
| ALRELMKLAPRYKLG | 536 | Q7Z3S7 | |
| KLGIYEAMKIGLVRP | 2271 | P15924 | |
| LMRLNQLKPGLQYKL | 406 | Q12906 | |
| KLKPELMGLIRQQRL | 526 | Q96BJ8 | |
| EIRKLRQDILLMKPY | 366 | Q6ZN54 | |
| MLLNKPLYLNIALLK | 251 | A6NNW6 | |
| YAKVKLIRLVGIMLL | 416 | P32019 | |
| KNYGKILLPDTNLML | 2446 | Q9NZJ4 | |
| KLNYLDIGEIKKRPM | 96 | Q9UHG0 | |
| MLKKFERLNIPNLGI | 571 | Q8TE73 | |
| PLRYPVLMNRKKCLL | 126 | Q8NH01 | |
| YMEPILKALILKLKD | 771 | P42345 | |
| KMLFPLLEELGRKYQ | 421 | Q8N807 | |
| KLEPRGLIYVKVTLM | 781 | Q5VT97 | |
| LPAFNVLKLIGLMYL | 581 | Q7Z5M5 | |
| SAVPYKRLMLLQIKG | 1436 | O95425 | |
| LGYRLPLNDKEIKRM | 7416 | Q8NF91 | |
| LEIKALRMKLGPLQF | 131 | P0DP42 | |
| ELVSYPKLKLKIMIR | 121 | Q5TGI4 | |
| LKPIQRMGKYALLLQ | 861 | Q58EX7 | |
| KNMDKIRLPSLYDLI | 371 | Q9H1N7 | |
| MLLRYLLEPKAGKEK | 26 | O75192 | |
| FGLMKNLIRRLQKYP | 316 | Q8WTW4 | |
| YKRVMPDGKIQKLII | 96 | Q9NSD9 | |
| LYDKGLLLTKMPLAL | 626 | Q9H6W3 | |
| NILIILRNMGYLKPR | 81 | Q01718 | |
| RQLEMILNKPGLKYK | 171 | Q04828 | |
| RLLEMILNKPGLKYK | 171 | P52895 | |
| LDLLSKMLIYDPAKR | 261 | P06493 | |
| RKYSVDLLMDLLKNP | 251 | Q8TCG1 | |
| MLLRLKSVLYLPGDF | 536 | Q9NQW8 | |
| MLKLLALRQLPDIYP | 896 | Q6ZRI6 | |
| KPMQILYKGTLRVLL | 2086 | A5YKK6 | |
| YKPKRLGNDIALMKL | 296 | P57727 | |
| GFDILLMKNLKPILL | 516 | Q8NHH1 | |
| KLGPALKIYARISML | 841 | Q8IXK0 | |
| KQLLYLEKYRPKMRL | 141 | Q12974 | |
| LLPLLTMAYLKGDLR | 351 | Q8TCT6 | |
| KPKLNTLKLYRLLPM | 406 | Q9P1Z0 | |
| KLMRPLNALDELYRL | 1471 | Q70Z35 | |
| LPYMIRSKLKLLLQG | 3041 | P78527 | |
| MSRPLLGLILLNEKY | 1001 | Q9UIA9 | |
| VPMQRVLKYHLLLKE | 331 | P52735 | |
| YISRGELLLKMNKPL | 566 | Q6ZXV5 | |
| LPQLKELYISRNKLM | 476 | O60603 | |
| LLIKPVQRIMKYQLL | 2096 | O75962 | |
| LKRLMAEYKQLTLNP | 6 | P60604 | |
| LKSFGQMLLKYILRP | 241 | O43264 | |
| KAYSLGDLPMKLQRI | 426 | P48549 | |
| LKEYKQSRGLMPIKI | 356 | Q96M32 | |
| IIDYFRKMPLLLIDG | 501 | Q13094 | |
| RMPLLLNPKLLSLEY | 556 | O15146 | |
| SYVRALPLLKKMGIN | 46 | Q53FP2 |